- Home
- TENX vs CODX Comparison
TENX vs CODX Comparison
Compare TENX & CODX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TENX
- CODX
- Stock Information
- Founded
- TENX 1967
- CODX 2013
- Country
- TENX United States
- CODX United States
- Employees
- TENX N/A
- CODX N/A
- Industry
- TENX Biotechnology: Pharmaceutical Preparations
- CODX Medical/Dental Instruments
- Sector
- TENX Health Care
- CODX Health Care
- Exchange
- TENX Nasdaq
- CODX Nasdaq
- Market Cap
- TENX 21.6M
- CODX 11.9M
- IPO Year
- TENX N/A
- CODX 2017
- Fundamental
- Price
- TENX $5.82
- CODX $0.36
- Analyst Decision
- TENX Strong Buy
- CODX Buy
- Analyst Count
- TENX 3
- CODX 2
- Target Price
- TENX $16.00
- CODX $5.50
- AVG Volume (30 Days)
- TENX 13.0K
- CODX 105.9K
- Earning Date
- TENX 05-20-2025
- CODX 05-08-2025
- Dividend Yield
- TENX N/A
- CODX N/A
- EPS Growth
- TENX N/A
- CODX N/A
- EPS
- TENX N/A
- CODX N/A
- Revenue
- TENX N/A
- CODX $3,915,160.00
- Revenue This Year
- TENX N/A
- CODX N/A
- Revenue Next Year
- TENX N/A
- CODX N/A
- P/E Ratio
- TENX N/A
- CODX N/A
- Revenue Growth
- TENX N/A
- CODX N/A
- 52 Week Low
- TENX $2.77
- CODX $0.28
- 52 Week High
- TENX $7.89
- CODX $2.23
- Technical
- Relative Strength Index (RSI)
- TENX 52.41
- CODX 45.27
- Support Level
- TENX $5.34
- CODX $0.34
- Resistance Level
- TENX $5.87
- CODX $0.38
- Average True Range (ATR)
- TENX 0.34
- CODX 0.03
- MACD
- TENX 0.04
- CODX 0.01
- Stochastic Oscillator
- TENX 86.99
- CODX 50.29
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.